|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: CONCORD Working Group: Global surveillance of cancer
survival 1995–2009: Analysis of individual data for 25,676,887
patients from 279 population-based registries in 67 countries
(CONCORD-2). Lancet. 385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Faubion WA, Guicciardi ME, Miyoshi H,
Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH and Gores GJ: Toxic
bile salts induce rodent hepatocyte apoptosis via direct activation
of Fas. J Clin Invest. 103:137–145. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sodeman T, Bronk SF, Roberts PJ, Miyoshi H
and Gores GJ: Bile salts mediate hepatocyte apoptosis by increasing
cell surface trafficking of Fas. Am J Physiol Gastrointest Liver
Physiol. 278:G992–G999. 2000.PubMed/NCBI
|
|
5
|
Jones BA, Rao YP, Stravitz RT and Gores
GJ: Bile salt-induced apoptosis of hepatocytes involves activation
of protein kinase C. Am J Physiol. 272:G1109–G1115. 1997.PubMed/NCBI
|
|
6
|
Gonzalez B, Fisher C and Rosser BG:
Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is
associated with early modulation of intracellular PKC activity. Mol
Cell Biochem. 207:19–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsuchiya S, Tsuji M, Morio Y and Oguchi K:
Involvement of endoplasmic reticulum in glycochenodeoxycholic
acid-induced apoptosis in rat hepatocytes. Toxicol Lett.
166:140–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Metalli V Drudi, Mancino MG, Mancino A,
Torrice A, Gatto M, Attili AF, Alpini G and Alvaro D: Bile salts
regulate proliferation and apoptosis of liver cells by modulating
the IGF1 system. Dig Liver Dis. 39:654–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang K, Brems JJ, Gamelli RL and Ding J:
Reversibility of caspase activation and its role during
glycochenodeoxycholate-induced hepatocyte apoptosis. J Biol Chem.
280:23490–23495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang K, Brems JJ, Gamelli RL and Holterman
AX: Survivin signaling is regulated through nuclear factor-kappa B
pathway during glycochenodeoxycholate-induced hepatocyte apoptosis.
Biochim Biophys Acta. 1803:1368–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Webster CR, Johnston AN and Anwer MS:
Protein kinase Cδ protects against bile acid apoptosis by
suppressing proapoptotic JNK and BIM pathways in human and rat
hepatocytes. Am J Physiol Gastrointest Liver Physiol.
307:G1207–G1215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoon JH, Werneburg NW, Higuchi H, Canbay
AE, Kaufmann SH, Akgul C, Edwards SW and Gores GJ: Bile acids
inhibit Mcl-1 protein turnover via an epidermal growth factor
receptor/Raf-1-dependent mechanism. Cancer Res. 62:6500–6505.
2002.PubMed/NCBI
|
|
13
|
Jaiswal K, Tello V, Lopez-Guzman C,
Nwariaku F, Anthony T and Sarosi GA Jr: Bile salt exposure causes
phosphatidyl-inositol-3-kinase-mediated proliferation in a Barretts
adenocarcinoma cell line. Surgery. 136:160–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jaiswal K, Lopez-Guzman C, Souza RF,
Spechler SJ and Sarosi GA Jr: Bile salt exposure increases
proliferation through p38 and ERK MAPK pathways in a non-neoplastic
Barretts cell line. Am J Physiol Gastrointest Liver Physiol.
290:G335–G342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komichi D, Tazuma S, Nishioka T, Hyogo H
and Chayama K: Glycochenodeoxycholate plays a carcinogenic role in
immortalized mouse cholangiocytes via oxidative DNA damage. Free
Radic Biol Med. 39:1418–1427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Akl H, Vervloessem T, Kiviluoto S,
Bittremieux M, Parys JB, De Smedt H and Bultynck G: A dual role for
the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus
endoplasmic reticulum. Biochim Biophys Acta. 1843:2240–2252. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsujimoto Y: Bcl-2 family of proteins:
Life-or-death switch in mitochondria. Biosci Rep. 22:47–58. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng X, Gao F, Flagg T and May WS Jr:
Mono- and multisite phosphorylation enhances Bcl2s antiapoptotic
function and inhibition of cell cycle entry functions. Proc Natl
Acad Sci USA. 101:153–158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng X, Ruvolo P, Carr B and May WS Jr:
Survival function of ERK1/2 as IL-3-activated,
staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci USA.
97:1578–1583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng X, Xiao L, Lang W, Gao F, Ruvolo P
and May WS Jr: Novel role for JNK as a stress-activated Bcl2
kinase. J Biol Chem. 276:23681–23688. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Wu Z, Hong W, Wang Z, Peng D,
Chen J, Yuan C, Yu S, Xu L and Fang Y: Influence of BCL2 gene in
major depression susceptibility and antidepressant treatment
outcome. J Affect Disord. 155:288–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moreno-Galindo C, Hermsen M,
García-Pedrero JM, Fresno MF, Suárez C and Rodrigo JP: p27 and BCL2
expression predicts response to chemotherapy in head and neck
squamous cell carcinomas. Oral Oncol. 50:128–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu P, Liu L, Wang J, Zhang K, Hong X, Deng
Q, Xiang J, Zhang X, He M, Wu T, et al: Genetic variation in BCL2
3-UTR was associated with lung cancer risk and prognosis in male
Chinese population. PLoS One. 8:e721972013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mehta SV, Shukla SN and Vora HH:
Overexpression of Bcl2 protein predicts chemoresistance in acute
myeloid leukemia: Its correlation with FLT3. Neoplasma. 60:666–675.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dorjgochoo T, Xiang YB, Long J, Shi J,
Deming S, Xu WH, Cai H, Cheng J, Cai Q, Zheng W, et al: Association
of genetic markers in the BCL-2 family of apoptosis-related genes
with endometrial cancer risk in a Chinese population. PLoS One.
8:e609152013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang TQ, Luo XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paulus A, Chitta K, Akhtar S, Personett D,
Miller KC, Thompson KJ, Carr J, Kumar S, Roy V, Ansell SM, et al:
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic
effects of lenalidomide and dexamethasone in preclinical models of
multiple myeloma and Waldenström macroglobulinaemia. Br J Haematol.
164:352–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao F, Han Q, Zhong C and Zhao H: TRAF6
promoted the tumorigenicity of esophageal squamous cell carcinoma.
Tumour Biol. 34:3201–3207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Petrasek J, Iracheta-Vellve A, Csak T,
Satishchandran A, Kodys K, Kurt-Jones EA, Fitzgerald KA and Szabo
G: STING-IRF3 pathway links endoplasmic reticulum stress with
hepatocyte apoptosis in early alcoholic liver disease. Proc Natl
Acad Sci USA. 110:16544–16549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY,
Cui YM, Qi L, Wu P, Jiao HL, Xie YJ, et al: MicroRNA-30b functions
as a tumour suppressor in human colorectal cancer by targeting
KRAS, PIK3CD and BCL2. J Pathol. 232:415–427. 2013. View Article : Google Scholar
|
|
33
|
Hu J, Fang Y, Cao Y, Qin R and Chen Q:
miR-449a regulates proliferation and chemosensitivity to cisplatin
by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci.
59:336–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Drukker L, Margulis A, Chaouat M, Levitzki
R, Maiorenko E and Ben Bassat H: Changes of PI3K/AKT/BCL2 signaling
proteins in congenital Giant Nevi: Melanocytes contribute to their
increased survival and integrity. J Recept Signal Transduct Res.
33:359–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kurosawa H, Que FG, Roberts LR, Fesmier PJ
and Gores GJ: Hepatocytes in the bile duct-ligated rat express
Bcl-2. Am J Physiol. 272:G1587–G1593. 1997.PubMed/NCBI
|
|
36
|
Wang J and Zou S: The bcl-2 mRNA
expression in GCDC-induced obstructive jaundice in rats and its
implication in hepatocellular apoptosis. J Huazhong Univ Sci
Technolog Med Sci. 22:34–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liao M, Zhao J, Wang T, Duan J, Zhang Y
and Deng X: Role of bile salt in regulating Mcl-1 phosphorylation
and chemoresistance in hepatocellular carcinoma cells. Mol Cancer.
10:442011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hylemon PB, Zhou H, Pandak WM, Ren S, Gil
G and Dent P: Bile acids as regulatory molecules. J Lipid Res.
50:1509–1520. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sipka S and Bruckner G: The
immunomodulatory role of bile acids. Int Arch Allergy Immunol.
165:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li T and Chiang JY: Bile acid signaling in
metabolic disease and drug therapy. Pharmacol Rev. 66:948–983.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Debruyne PR, Bruyneel EA, Li X, Zimber A,
Gespach C and Mareel MM: The role of bile acids in carcinogenesis.
Mutat Res. 480–481:359–369. 2001. View Article : Google Scholar
|
|
42
|
Lozano E, Sanchez-Vicente L, Monte MJ,
Herraez E, Briz O, Banales JM, Marin JJ and Macias RI:
Cocarcinogenic effects of intrahepatic bile acid accumulation in
cholangiocarcinoma development. Mol Cancer Res. 12:91–100. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang X, Sun D, Tian Y, Ling S and Wang L:
Metformin sensitizes hepatocellular carcinoma to arsenic
trioxide-induced apoptosis by downregulating Bcl2 expression.
Tumour Biol. 36:2957–2964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chio CC, Lin JW, Cheng HA, Chiu WT, Wang
YH, Wang JJ, Hsing CH and Chen RM: MicroRNA-210 targets
antiapoptotic Bcl-2 expression and mediates hypoxia-induced
apoptosis of neuroblastoma cells. Arch Toxicol. 87:459–468. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rooswinkel RW, van de Kooij B, Verheij M
and Borst J: Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w
and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or
Bcl-B. Cell Death Dis. 3:e3662012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Du P, Cao H, Wu HR, Zhu BS, Wang HW, Gu
CW, Xing CG and Chen W: Blocking Bcl-2 leads to autophagy
activation and cell death of the HEPG2 liver cancer cell line.
Asian Pac J Cancer Prev. 14:5849–5854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ko TK, Chuah CT, Huang JW, Ng KP and Ong
ST: The BCL2 inhibitor ABT-199 significantly enhances
imatinib-induced cell death in chronic myeloid leukemia
progenitors. Oncotarget. 5:9033–9038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han B, Park D, Li R, Xie M, Owonikoko TK,
Zhang G, Sica GL, Ding C, Zhou J, Magis AT, et al: Small-molecule
Bcl2 BH4 antagonist for lung cancer therapy. Cancer Cell.
27:852–863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mai H, May WS, Gao F, Jin Z and Deng X: A
functional role for nicotine in Bcl2 phosphorylation and
suppression of apoptosis. J Biol Chem. 278:1886–1891. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ruvolo PP, Deng X, Carr BK and May WS: A
functional role for mitochondrial protein kinase Calpha in Bcl2
phosphorylation and suppression of apoptosis. J Biol Chem.
273:25436–25442. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jin Z, Gao F, Flagg T and Deng X:
Tobacco-specific nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional
cooperation of Bcl2 and c-Myc through phosphorylation in regulating
cell survival and proliferation. J Biol Chem. 279:40209–40219.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hou Y, Gao F, Wang Q, Zhao J, Flagg T,
Zhang Y and Deng X: Bcl2 impedes DNA mismatch repair by directly
regulating the hMSH2-hMSH6 heterodimeric complex. J Biol Chem.
282:9279–9287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao J, Gao F, Zhang Y, Wei K, Liu Y and
Deng X: Bcl2 inhibits abasic site repair by down-regulating APE1
endonuclease activity. J Biol Chem. 283:9925–9932. 2008. View Article : Google Scholar : PubMed/NCBI
|
